Skip to main content
Screener/Healthcare/Biotechnology

NGNE — Neurogene Inc.

NASDAQ
$38.47+0.86 (+2.29%)
Small CapUnder $50HealthcareHigh Beta
$15.93
$43.66
$36.56
$39.38
EPS (TTM)$-5.03
P/E Ratio-4.71
Dividend Yield—
Market Cap$606.2M
Volume179K
Prev Close$37.61
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$30.9M$-1.39——
Q4 '25$0-$24.7M$-1.60——
Q3 '25$0-$21.0M$-0.99——
Q2 '25$0-$22.0M$-1.05——
Q1 '25$0-$22.6M$-1.08——
Q4 '24$0-$19.5M$-1.31——
Q3 '24$0-$20.2M$-1.19——
Q2 '24$925K-$18.5M$-1.0911.7%-1999.1%
Get Your Daily Market Recap
NGNE Stock Price, Chart & Analysis